These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28445233)

  • 1. Preclinical models for translational sarcoma research.
    Hamacher R; Bauer S
    Curr Opin Oncol; 2017 Jul; 29(4):275-285. PubMed ID: 28445233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Derived Xenograft: An Adjuvant Technology for the Treatment of Metastatic Disease.
    Bousquet G; Janin A
    Pathobiology; 2016; 83(4):170-6. PubMed ID: 27010922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.
    Liu T; Shen JK; Li Z; Choy E; Hornicek FJ; Duan Z
    Cancer Lett; 2016 Apr; 373(1):109-118. PubMed ID: 26806808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
    Ruggeri BA; Camp F; Miknyoczki S
    Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors.
    Gaudenzi G; Albertelli M; Dicitore A; Würth R; Gatto F; Barbieri F; Cotelli F; Florio T; Ferone D; Persani L; Vitale G
    Endocrine; 2017 Aug; 57(2):214-219. PubMed ID: 27481363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models for modeling pancreatic cancer and novel drug discovery.
    Bisht S; Feldmann G
    Expert Opin Drug Discov; 2019 Feb; 14(2):127-142. PubMed ID: 30657339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rodent models for human diseases.
    Vandamme TF
    Eur J Pharmacol; 2015 Jul; 759():84-9. PubMed ID: 25823811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choosing wisely - Preclinical test models in the era of precision medicine.
    Klinghammer K; Walther W; Hoffmann J
    Cancer Treat Rev; 2017 Apr; 55():36-45. PubMed ID: 28314175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis.
    Kerbel RS; Guerin E; Francia G; Xu P; Lee CR; Ebos JM; Man S
    Breast; 2013 Aug; 22 Suppl 2():S57-65. PubMed ID: 24074794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop.
    Hingorani P; Janeway K; Crompton BD; Kadoch C; Mackall CL; Khan J; Shern JF; Schiffman J; Mirabello L; Savage SA; Ladanyi M; Meltzer P; Bult CJ; Adamson PC; Lupo PJ; Mody R; DuBois SG; Parsons DW; Khanna C; Lau C; Hawkins DS; Randall RL; Smith M; Sorensen PH; Plon SE; Skapek SX; Lessnick S; Gorlick R; Reed DR
    Cancer Genet; 2016 May; 209(5):182-94. PubMed ID: 27132463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1, derived from a patient with undifferentiated pleomorphic sarcoma.
    Oyama R; Kito F; Sakumoto M; Shiozawa K; Toki S; Yoshida A; Kawai A; Kondo T
    In Vitro Cell Dev Biol Anim; 2018 Mar; 54(3):257-263. PubMed ID: 29359268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments of transgenic and xenograft mouse models of pancreatic cancer for translational research.
    Schütte U; Bisht S; Brossart P; Feldmann G
    Expert Opin Drug Discov; 2011 Jan; 6(1):33-48. PubMed ID: 22646825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
    Paez-Ribes M; Man S; Xu P; Kerbel RS
    PLoS One; 2016; 11(6):e0158034. PubMed ID: 27355476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
    Poste G
    Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review of the Current Status of Human Sarcoma Cell Lines.
    Hattori E; Oyama R; Kondo T
    Cells; 2019 Feb; 8(2):. PubMed ID: 30781855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-derived xenografts as tools in pharmaceutical development.
    Izumchenko E; Meir J; Bedi A; Wysocki PT; Hoque MO; Sidransky D
    Clin Pharmacol Ther; 2016 Jun; 99(6):612-21. PubMed ID: 26874468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoproteomics in translational research: a sarcoma perspective.
    Noujaim J; Payne LS; Judson I; Jones RL; Huang PH
    Ann Oncol; 2016 May; 27(5):787-94. PubMed ID: 26802162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in patient-derived tumor xenografts: from target identification to predicting clinical response rates in oncology.
    Rosfjord E; Lucas J; Li G; Gerber HP
    Biochem Pharmacol; 2014 Sep; 91(2):135-43. PubMed ID: 24950467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.
    Mazur PK; Siveke JT
    Gut; 2012 Oct; 61(10):1488-500. PubMed ID: 21873467
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.